企業プロフィール
Myomo 株価・ニュース・カタリスト
- ティッカー:
- MYO
- 取引所:
- NYSE
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
1.61 USD (+3.21%)
終値
最終更新: 2026年10月1日
41M USD
時価総額
株価変動の要因
2026年10月1日 時点で MYO は 3.21% 上昇し、$1.61 で取引を終えました。現在のニュース監視期間内に同社の新しいニュースは確認されませんでした。
企業概要
Powered Orthotics Company
Myomo develops wearable robotic orthoses for people with impaired arm and hand function. Its devices are intended to help patients perform daily activities after stroke, nerve injury, and other neuromuscular conditions.
MyoPro Product Family
MyoPro detects weak electrical signals from a user's muscles and translates them into powered movement at the elbow, wrist, or hand. Each orthosis is customized to the patient's anatomy and functional needs.
Neuromuscular Patient Population
The device is used by people with upper-limb weakness resulting from stroke, brachial plexus injury, spinal cord injury, multiple sclerosis, and other conditions. Candidates typically retain enough muscle signal to control the powered brace.
Direct-to-Patient Model
Myomo markets directly to prospective users, conducts remote or in-person screening, and works with clinicians and orthotics professionals to complete evaluation and fitting. Patient advocacy and digital lead generation are important to demand creation.
Reimbursement and Fabrication
Revenue depends on insurance authorization and payment, including Medicare and commercial plans. Centralized fabrication, clinical documentation, and claims support help move qualified patients from evaluation to delivery.
今後のカタリスト
最近のニュース
ニュースタイトルは機械翻訳です。詳細は英語の原文をご覧ください。
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。